Nareg Sagherian
Head of Global Investor Relations & Corporate CommunicationsMr. Nareg Sagherian serves as Head of Global Investor Relations and Corporate Communications of Evolus, Inc. since January 2024. Prior to joining Evolus, he was the Executive Director, Head of Global Investor Relations, Corporate Affairs for Intercept Pharmaceuticals. He brings extensive experience in capital markets, investor relations, corporate communications, and public policy to Evolus from firms including FTI Consulting, Biotechnology Innovation Organization and Booz Allen Hamilton. He serves as Executive Director of Global Investor Relations at Intercept Pharmaceuticals, Inc. since December 2021. He also spent in the public sector at the U.S. Department of the Treasury and U.S. Small Business Administration. He received an M.B.A. from the University of Virginias Darden School of Business, a Graduate Diploma in Legislative Studies from the Georgetown University Government Affairs Institute, a M.S. in Corporate Finance and a Graduate Diploma in Investments from the Johns Hopkins University Carey Business School, and a M.S. in Medical Sciences from the Wayne State University School of Medicine.
Positions
- Company NameEvolus, Inc.Stock CodeEOLSPositionHead of Global Investor Relations & Corporate CommunicationsColleagues
- DMDavid MoatazediPresident, CEO & Director
- VMVikram MalikIndependent Chairman of the Board
- TMTatjana MitchellChief Financial Officer
- RARui AvelarChief Medical Officer and Head of Research & Development
- KKKurt KnabSenior Vice President of Sales
- DNDavid N. GillIndependent Director
- KHKarah Herdman ParschauerIndependent Director
- AGAlbert G. WhiteIndependent Director
